E-mail a Wiley Online Library Link

Bernard Escudier Progression-free survival as a surrogate marker of overall survival Cancer 117

Version of Record online: 1 FEB 2011 | DOI: 10.1002/cncr.25955

The use of progression-free survival as a surrogate marker of efficacy in cancer treatment has been the subject of much discussion in recent years. However, it should not be considered a surrogate marker for overall survival.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field